Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Forum for Health Economics & Policy

Editor-in-Chief: Goldman, Dana

2 Issues per year


CiteScore 2016: 0.30

SCImago Journal Rank (SJR) 2016: 0.140
Source Normalized Impact per Paper (SNIP) 2016: 0.098

Online
ISSN
1558-9544
See all formats and pricing
More options …

Measuring the Financial Exposure from Medical Care Spending Among Families with Employer Sponsored Insurance

Jean M. Abraham
  • Corresponding author
  • Health Policy and Management, University of Minnesota, Twin Cities, 420 Delaware Street SE MMC 729, Minneapolis, MN 55455, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Anne Beeson Royalty / Thomas DeLeire
Published Online: 2013-07-31 | DOI: https://doi.org/10.1515/fhep-2012-0012

Abstract

We develop an empirical method to assess the degree of financial exposure associated with medical care spending among non-elderly US families with employer-sponsored insurance. A key feature of this method is its simplicity – it only requires data on out-of-pocket (OOP) health care spending and total health care spending and does not require detailed knowledge of health insurance benefit design. We apply our method to assess whether families with a chronically ill member face more financial exposure given their level of total spending relative to families with no chronically ill members. We find that the insured chronically ill face more financial exposure than the insured non-chronically ill. Additional analyses suggest that the reason for this additional financial exposure is not that families with a chronically ill member are in different, less generous plans, on average. Rather, families with a chronically ill member have higher spending on certain types of medical services (e.g., pharmaceuticals) that face higher levels of coinsurance. Given recent work on value-based insurance design and coinsurance as an obstacle to medication adherence, our findings suggest that the current design of health plans could jeopardize both the health and the financial well-being of the chronically ill.

Keywords: chronic illness; health insurance; medical care spending

References

  • Abraham, J. M., T. DeLeire and A. Royalty (2010) “Moral Hazard Matters: Measuring Relative Rates of Underinsurance Using Threshold Measures,” Health Services Research, 45(3):806–824.Web of SciencePubMedCrossrefGoogle Scholar

  • Anderson, G. J. (2010) Chronic Care: Making the Case for Ongoing Care. Prepared by Partnership for Solutions, Johns Hopkins University for the Robert Wood Johnson Foundation. Available at: http://www.rwjf.org/files/research/50968chronic.care.chartbook.pdf (accessed January 25. 2011).

  • Banthin, J. and D. Bernard (2006) “Changes in Financial Burdens for Health Care: National Estimates for the Population Younger than 65 Years, 1996 to 2003,” Journal American Medical Association, 296(22):2712–2719.Google Scholar

  • Banthin, J., P. Cunningham and D. Bernard (2008) “Financial Burden of Health Care 2001–2004,” Health Affairs, 27(1):188–195.CrossrefGoogle Scholar

  • Bodenheimer, T., E. Chen and H. Bennett (2009) “Confronting the Growing Burden of Chronic Disease: Can the U.S. Health Care Workforce Do the Job?” Health Affairs, 28(1):64–74.CrossrefWeb of ScienceGoogle Scholar

  • Chandra, A., J. Gruber and R. McKnight (2010) “Patient Cost-Sharing and Hospitalization Offsets in the Elderly,” American Economic Review, 100(1):193–213.CrossrefWeb of ScienceGoogle Scholar

  • Chernew, M. E., M. R. Shah, A. Wegh, S. N. Rosenberg, I. A. Juster, A. B. Rosen, M. C. Sokol, K. Yu-Isenberg and A. M. Fendrick (2008) “Impact of Decreasing Copayments on Medication Adherence Within a Disease Management Environment,” Health Affairs, 27(1):103–112.CrossrefWeb of ScienceGoogle Scholar

  • Choudhry, N. K., J. Avorn, E. M. Antman, S. Schneeweiss and W. H. Shrank (2007) “Should Patients Receive Secondary Prevention Medications for Free After a Myocardial Infarction?,” Health Affairs, 26(1):186–194.Web of ScienceCrossrefGoogle Scholar

  • Cunningham, P. J. (2010) “The Growing Financial Burden of Health Care: National and State Trends, 2001–2006,” Health Affairs, 29(5):1037–1044.Web of ScienceCrossrefGoogle Scholar

  • Davidoff, A. and G. Kenney (2005) “Uninsured Americans with Chronic Conditions: Key Findings from the National Health Interview Survey.” Robert Wood Johnson Foundation Report for Cover the Uninsured Week, 2005.Google Scholar

  • Fendick, A. M., M. Chernew and G. Levi (2009) “Value-Based Insurance Design: Embracing Value over Cost Alone.” American Journal of Managed Care, 15:S277–S283.Google Scholar

  • Gabel, J., R. McDevitt, L. Gandolfo, J. Pickreign, S. Hawkins and C. Fahlman (2006) “Generosity and Adjusted Premiums in Job-Based Insurance: Hawaii is Up, Wyoming is Down,” Health Affairs, 25(3):832–843.CrossrefGoogle Scholar

  • Gabel, J., J. Pickreign, R. McDevitt, H. Whitmore, L. Candolfo, R. Lore and K. Wilson (2007) “Trends in the Golden State: Small-Group Premiums Rise Sharply While Actuarial Values for Individual Coverage Plummet,” Health Affairs, 26(4):w488–w499.Web of ScienceCrossrefGoogle Scholar

  • Gabel, J., R. Lore, R. McDevitt, J. Pickreign, H. Whitmore, M. Slover and E. Levy-Forsythe (2012) “More than Half of Individual Health Plans Offer Coverage That Falls Short of What Can Be Sold Through Exchanges As of 2014,” Health Affairs, 31(6). Available at: http://content.healthaffairs.org/content/early/2012/05/22/hlthaff.2011.1082.full (accessed June, 2012).Web of Science

  • Gaynor, M., J. Li and W. B. Vogt (2007) Substitution, Spending Offsets, and Prescription Drug Benefit Design,” Forum for Health Economics & Policy, 10(2): Article 4. Available at: http://www.bepress.com/fhep/10/2/4.

  • Goldman, D. P., G. F. Joyce, J. J. Escarce, J. E. Pace, M. D. Solomon, M. Laouri, et al. (2004) “Pharmacy Benefits and the Use of Drugs by the Chronically Ill,” Journal American Medical Association, 291(19): 2344–2350.Google Scholar

  • Goldman, D. P., G. F. Joyce and P. Karaca-Mandic (2006) “Varying Pharmacy Benefits with Clinical Status: The Case of Cholesterol-Lowering Therapy,” The American Journal of Managed Care, 12(1):21–28.PubMedGoogle Scholar

  • Joyce, G. F., J. J. Escarce, M. D. Solomon and D. P. Goldman (2002) “Employer Drug Benefit Plans and Spending on Prescription Drugs,” Journal American Medical Association, 288(14):1733–1739.Google Scholar

  • Kaiser Family Foundation and Health Research and Educational Trust (2011) “Employer Health Benefits 2011 Annual Survey.” Available at: www.kff.org (accessed March 2012).

  • Karaca-Mandic, P., A. Jena, G. Joyce and D. Goldman (2012) “Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children with Asthma.” Journal American Medical Association, 307(12):1284–1291.Google Scholar

  • Leibowitz, A., W. G. Manning and J. P. Newhouse (1985) “The Demand for Prescription Drugs as a Function of Cost-Sharing,” Soc Sci Med. 21:1063–1069.CrossrefPubMedGoogle Scholar

  • Machlin, S., J. Cohen and K. Beauregard (2008) “Health Care Expenses for Adults with Chronic Conditions, 2005,” MEPS Statistical Brief No. 203, May 2008. Available at: www.meps.ahrq.gov (accessed May, 2010).

  • McDevitt, R. (2008) “Actuarial Value: A Method for Comparing Health Plan Benefits.” Available at: http://www.chcf.org/~/media/Files/PDF/H/HealthPlanActuarialValue.pdf, (accessed May, 2010).

  • McDevitt, R., J. Gabel, R. Lore, J. Pickreign, H. Whitmore and T. Brust (2010) “Group Insurance: A Better Deal for Most Plans than Individual Plans.” Health Affairs, 29(1):156–164.CrossrefWeb of ScienceGoogle Scholar

  • Peterson, C. (2009) “Setting and Valuing Health Insurance Benefits.” Congressional Research Service Report for Congress, R40491, April 6, 2009.Google Scholar

  • Schoen, C., S. Collins, J. Kriss and M. Doty (2008) “How Many are Underinsured? Trends Among U.S. Adults, 2003 and 2007,” Health Affairs, 27(4): w298–309.CrossrefWeb of ScienceGoogle Scholar

  • Short, P. and J. Banthin (1995) “New Estimates of the Underinsured Younger than 65 Years.” Journal American Medical Association, 274(16):1302–1306.Google Scholar

About the article

Corresponding author: Jean M. Abraham, Health Policy and Management, University of Minnesota, Twin Cities, 420 Delaware Street SE MMC 729, Minneapolis, MN 55455, USA, Tel.: +612-625-4375, e-mail:


Published Online: 2013-07-31

Published in Print: 2013-01-01


The exception to this is the 1996 MEPS-HC when health insurance benefits booklets were abstracted.

While the issue of financial exposure is pertinent to the Medicare-eligible population as well, it is challenging to contrast those with and without chronic illness, given the high prevalence of chronic conditions in this population. Moreover, comparisons between the Medicare and non-Medicare eligible populations are difficult given the different financing systems for the two groups.

Few families, if any, are fully insured from the risk of medical expenses. While a large amount of attention is placed on differences between the insured and uninsured, we want to focus on variability in financial exposure among those with coverage.

We acknowledge that the restrictions we impose on our sample may limit the extent to which these results may generalize to the under-65, privately insured population overall.

Families that have health insurance that provides less financial exposure may be more likely to seek medical care in which they will be diagnosed with a chronic condition, a possibility that might lead us to understate the differences in the degree of financial exposure from insurance between chronically ill families and non-chronically ill families.

We recoded multi-race families to reflect the less prevalent race in the population.

In the case of the family holding two plans, we sum each plan’s OOP premium to arrive at the family-level measure.

A small percentage of families reports having two policyholders. In this case, we defined the variable as equal to one if either of the policyholder’s had the particular attribute (e.g., worked for a small establishment, private organization, or belonged to a union).

Survey commands in STATA do not allow for explicit clustering to account for repeated observations on families, which is present given the overlapping panel design. When we re-estimated the model without explicit survey commands but utilized analytic weights and allowed for clustering, the standard errors are almost identical. Median regression is not supported by the survey commands. In this case, we used analytic weights with clustering. For robustness, we also considered alternative specifications including OLS regression and a square-root transformation. These results produced qualitatively similar patterns of results and are available from the corresponding author by request.

Approximately 18% of families in the sample have annual total spending in excess of $8000 per year.

A full set of model results is available from the corresponding author by request.

The reader should keep in mind that there is substantial heterogeneity in the plans held within the two groups. Our method aggregates across these plans and cannot speak to the frequency in which the individual plans held by the chronically ill are less generous, only to the average difference.

One might also want to consider longer-term or “lifetime” insurance curves that relate many years or lifetime OOP spending to total spending. The data we use (the MEPS) preclude our constructing these longer-term or lifetime measures. We suspect, however, that there is greater serial correlation in expenditures among the chronically ill than among those with acute conditions (almost by definition). Thus, a longer-term picture using our method would be likely to show an even larger difference in the degree of financial security from insurance between the chronically ill and the non-chronically ill.


Citation Information: Forum for Health Economics and Policy, Volume 16, Issue 1, Pages 193–217, ISSN (Online) 1558-9544, ISSN (Print) 2194-6191, DOI: https://doi.org/10.1515/fhep-2012-0012.

Export Citation

©2013 by Walter de Gruyter Berlin Boston. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Joelle Abramowitz, Brett O'Hara, and Darcy Steeg Morris
Health Economics, 2017, Volume 26, Number 4, Page 469

Comments (0)

Please log in or register to comment.
Log in